MEDISTIM ASA: årsregnskap 2023 vs 2022
Grew 10% on revenue
approved 2024-04-24; registry 2024-07-17; journal 2024 572172
Summary
What changed
Comparing Årsregnskap 2023 with 2022 for MEDISTIM ASA. Revenue 308.6k NOK → 341.0k NOK (+10.5%). Net result +108.11m NOK → +99.45m NOK. Equity 191.7k NOK → 214.8k NOK.
On the constructive side: revenue rose; equity strengthened. Pressures included: operating result weakened; net result weakened; cash fell.
Also worth watching: paid-in equity reduced; cogs moved; book investments changed. All figures are taken from the published annual accounts for MEDISTIM ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 308.6k NOK to 341.0k NOK (+10.5% YoY). Calculated
-
↑
Equity strengthened
Book equity 191.7k NOK → 214.8k NOK (equity ratio 50.2% → 53.4%). Calculated
What deteriorated
-
↓
Operating result weakened
Operating result +101.69m NOK → +108.0k NOK (op. margin 32948.2% → 31.7%). Calculated
-
↓
Net result weakened
Net result +108.11m NOK → +99.45m NOK (net margin 35026.3% → 29163.3%). Calculated
-
↓
Cash fell
Bank deposits 84.03m NOK → 82.48m NOK (-1.8% YoY). Calculated
-
↓
Current ratio dropped below 1×
Current ratio 1.85× → 0.00× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated
Things to notice
-
·
Paid-in equity reduced
Paid-in equity fell 65.16m NOK → 214.8k NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
COGS moved
COGS / varekostnad 63.99m NOK → 66.58m NOK (+4.0% YoY). Calculated
-
·
Book investments changed
Investment / intangible book value 49.37m NOK → 51.69m NOK. Reported fact